Connect with us

Business

Zymeworks Reports Incentive Grant Under New York Stock Exchange Listed Company Handbook Rule | Business

Published

on

 


VANCOUVER, British Columbia and SEATTLE–(BUSINESS WIRE)–January 15, 2022–

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutic products, today announced, as required by Rule 303A.08 of the New York Stock Exchange Listed Company Handbook (Rule NYSE), an equity incentive award to Mr. Kenneth Galbraith, incoming Zymeworks Chairman, President and Chief Executive Officer.

Pursuant to NYSE rule, Zymeworks has approved the grant of the following equity award to Mr. Galbraith as a material incentive for Mr. Galbraith to join Zymeworks: effective from the date his employment with Zymeworks commenced, an option to purchase 500,000 shares of common stock of the Company (the Options). The options have an exercise price per share of $14.97, equivalent to the closing price of the Company’s common stock on January 14, 2022, and have a maximum term of 10 years. Mr. Galbraith’s employment with the Company commenced on January 15, 2022 (the Start Date).

The options will vest over a four-year period as follows: (i) 1/4 of the options will vest on the first anniversary of the start date and (ii) 1/36 of the remaining options will vest on the last day of each following month the first anniversary of the start date until all options vest, subject to Mr. Galbraith’s continuous service. In addition, (i) if there is a change of control and within 12 months following or within three months preceding such change of control, his employment is terminated by the company without cause or (ii) in the event of death or disability, 100% of unvested options will become fully vested upon termination of employment or date of death or disability, as the case may be.

The options were granted outside of the Company’s Amended and Restated Stock and Stock Option Plan (the Current Plan) under the Stock Option Plan and recently adopted Zymeworks Inc. incentive stock plan and related option agreement, but will generally be subject to terms and conditions consistent with those of the current plan, except with respect to other terms and conditions intended to comply with the NYSE Incentive Award Exception.

About Zymeworks Inc.

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. The Zymeworks suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab, is a novel HER2-targeting azymetric bispecific antibody currently being evaluated in multiple Phase 1, Phase 2 and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. Zymeworks’ second clinical candidate, ZW49, is a novel HER2-targeting bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks’ proprietary ZymeLink linker and cytotoxin. Zymeworks is also advancing an extensive preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. Additionally, its therapeutic platforms are leveraged through strategic partnerships with global biopharmaceutical companies. For more information about our ongoing clinical trials, visit www.zymeworksclinicaltrials.com. For more information about Zymeworks, visit www.zymeworks.com and follow @Zymeworks Inc on Twitter.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220115005009/en/

CONTACT: Investor Inquiries:

Ryan Dercho, Ph.D.

(604) 678-1388

[email protected] Spinks

(604) 678-1388

[email protected] Inquiries:

Marie Klem

(604) 678-1388

[email protected]

KEYWORD: WASHINGTON UNITED STATES NORTH AMERICA CANADA

INDUSTRY KEYWORD: ONCOLOGY HEALTH GENERAL HEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY

SOURCE: Zymeworks Inc.

Copyright BusinessWire 2022.

PUBLISHED: 01/15/2022 08:30/DISC: 01/15/2022 08:32

http://www.businesswire.com/news/home/20220115005009/en

Copyright BusinessWire 2022.

Sources

1/ https://Google.com/

2/ https://www.valdostadailytimes.com/news/business/zymeworks-reports-inducement-grant-under-new-york-stock-exchange-listed-company-manual-rule/article_1bdc8d00-5418-5a7c-94be-4af4c725b53a.html

The mention sources can contact us to remove/changing this article

What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos

ExBUlletin

to request, modification Contact us at Here or [email protected]